Related references
Note: Only part of the references are listed.Application and interpretation of current autophagy inhibitors and activators
Ya-ping Yang et al.
ACTA PHARMACOLOGICA SINICA (2013)
The ULK1 complex Sensing nutrient signals for autophagy activation
Pui-Mun Wong et al.
AUTOPHAGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: TRANSPORTERS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil in PIK3CA mutant gastric cancer cells
Bhaskar Bhattacharya et al.
CANCER BIOLOGY & THERAPY (2012)
Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis
Suveera Dhup et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
LKB1 and AMP-activated protein kinase: regulators of cell polarity
Atsushi Nakano et al.
GENES TO CELLS (2012)
Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors
Markus P. Ghadimi et al.
MOLECULAR CANCER THERAPEUTICS (2012)
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Sang-Min Jeon et al.
NATURE (2012)
Multiple Metabolic Alterations Exist in Mutant PI3K Cancers, but Only Glucose Is Essential as a Nutrient Source
Rebecca Foster et al.
PLOS ONE (2012)
Metabolic approaches to overcoming chemoresistance in ovarian cancer
Dong Noon Suh et al.
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2011)
Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy
Cheng-Xiong Xu et al.
CANCER BIOLOGY & THERAPY (2011)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
Colon tumour cells increase PGE2 by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation
Heather R. Roberts et al.
CARCINOGENESIS (2011)
Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of Mitochondria
Corinne E. Griguer et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Synthetic lethality: General principles, utility and detection using genetic screens in human cells
Sebastian M. B. Nijman
FEBS LETTERS (2011)
The role of LKB1 and AMPK in cellular responses to stress and damage
Angela Alexander et al.
FEBS LETTERS (2011)
Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine
Joanna D. Holbrook et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
A Mechanism for Synergy with Combined mTOR and PI3 Kinase Inhibitors
Shujie Yang et al.
PLOS ONE (2011)
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
Qian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
GLUT1 enhances mTOR activity independently of TSC2 and AMPK
Carolyn L. Buller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Trastuzumab in gastric cancer
Alicia F. C. Okines et al.
EUROPEAN JOURNAL OF CANCER (2010)
mTOR regulation of autophagy
Chang Hwa Jung et al.
FEBS LETTERS (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation
Sakae Saito et al.
CANCER RESEARCH (2009)
Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry
Akiyoshi Hirayama et al.
CANCER RESEARCH (2009)
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
Vadivel Ganapathy et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies
Andrew Evans et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Chemotherapy of advanced gastric cancer
Fernando Rivera et al.
CANCER TREATMENT REVIEWS (2007)
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics
Rachel E. Airley et al.
CHEMOTHERAPY (2007)
Glucose regulated proteins in cancer progression, drug resistance and immunotherapy
Yong Fu et al.
CANCER BIOLOGY & THERAPY (2006)
Mutation of the PIK3CA oncogene in human cancers
B Karakas et al.
BRITISH JOURNAL OF CANCER (2006)
The prevalence of PIK3CA mutations in gastric and colon cancer
S Velho et al.
EUROPEAN JOURNAL OF CANCER (2005)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl
HK Li et al.
DIABETES (2005)
The SLC16 gene family -: from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond
AP Halestrap et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Share Paper
